市場調查報告書
商品編碼
1476413
睡茄萃取物市場預測至 2030 年:按類型、形式、功能、分銷管道、應用和地區進行的全球分析Ashwagandha Extract Market Forecasts to 2030 - Global Analysis By Type (KSM-66, Sensoril, Hydro-Alcoholic Ashwagandha, Crude Ashwagandha and Other Types), Form, Function, Distribution Channel, Application and By Geography |
根據 Stratistics MRC 的數據,2023 年睡茄萃取物的全球市場規模為 11 億美元,預計在預測期內將以 13.4% 的複合年成長率成長,並在 2030 年達到 26 億美元。
睡茄萃取物從睡茄植物的根中提取,是一種用於阿育吠陀醫學的古老草藥。 睡茄透過調節皮質醇水平幫助身體管理壓力。它還支持免疫功能並提高整體健康水平。它富含抗氧化劑,可以對抗發炎,改善大腦功能、記憶力和情緒。此外,睡茄萃取物可以降低血糖值並減輕焦慮和憂鬱症狀。
研究表明,食用大量睡茄會導致胃部不適、腹瀉、嘔吐和肝臟病變。它還會刺激腸道內壁並導致其他消化器官系統問題。
人們越來越認知到睡茄的健康益處
隨著越來越多人意識到睡茄的潛在健康的益處,對睡茄萃取物產品的需求也相應增加。消費者正在尋求自然療法來解決各種健康問題,包括壓力、焦慮、失眠和免疫支持。此外,製造商正在開發新的配方和交付方法,以使睡茄萃取物對消費者更容易獲得和更具吸引力。這種不斷成長的需求正在推動睡茄萃取物市場的成長。
有限的臨床研究
如果沒有可靠的臨床研究來支持其健康主張,睡茄萃取物可能很難在醫療保健專業人員和消費者中獲得信譽。對產品品質、純度和潛在副作用的擔憂可能會阻止一些消費者購買睡茄萃取物補充品。因此,缺乏科學檢驗會導致人們對其功效和安全性產生懷疑和不確定性,這可能會阻礙廣泛採用和市場成長。
對天然和草藥的需求不斷成長
隨著消費者尋求傳統藥物的天然替代品,對睡茄萃取物等草藥補充品的需求激增。注重健康的個人以及尋求緩解壓力、焦慮、疲勞和睡眠障礙等特定健康問題的人都會被睡茄萃取物所吸引。 睡茄被譽為適應性草藥,具有緩解壓力、免疫支持和整體健康等健康益處,與個人對整體解決方案的偏好非常一致,推動市場成長,我支持您。
可能的副作用
潛在副作用的存在可能會導致衛生當局和監管機構的監管監督。出於消費者安全的考慮,監管機構可能會對睡茄萃取物產品實施更嚴格的監管,包括標籤要求、劑量限制或在某些地區可能禁止。這可能會阻礙製造商和分銷商的市場進入和成長。
COVID-19 的影響
人們對睡茄的適應原特性和阿育吠陀醫學傳統用途的認知不斷提高,正在推動對補充品和萃取物的需求。關閉和健康問題加速了向線上購買管道的轉變,推動了市場的進一步成長。此外,研究顯示睡茄具有潛在的抗病毒和免疫調節特性,引起了消費者和研究人員的興趣,有助於提高市場在面對疫情挑戰時的彈性。
水醇南非睡茄細分市場預計將在預測期內成為最大的細分市場
水醇南非睡茄細分市場預計將出現良好的成長,因為它代表了這種草藥萃取物的特定配方,可能會吸引特定的消費者和產業。眾所周知,與其他萃取方法相比,水醇萃取可產生效力更高的濃縮萃取物。這種功效的增強可能會吸引尋求更有效補充品的消費者,從而進一步推動市場成長。
預計在預測期內,緩解焦慮和壓力產業的複合年成長率最高
隨著人們越來越認知到壓力與各種健康問題之間的聯繫,以及越來越多的消費者尋求自然療法來管理壓力和焦慮,預計焦慮和壓力減輕行業將在預測期內實現最高的複合年成長率。 睡茄作為適應原的聲譽使其成為尋求自然緩解壓力的個人的有吸引力的選擇。消費者基礎的擴大可以導致銷售增加和市場成長。
預計亞太地區在預測期內將佔據最大的市場佔有率。 睡茄是一種傳統的阿育吠陀草藥,幾個世紀以來一直用於治療各種健康狀況。隨著天然和有機產品越來越受歡迎,亞太地區的消費者越來越意識到睡茄的潛在健康益處。這些好處包括減輕壓力和焦慮、改善睡眠品質、增強免疫力和增加能量水平。預計這一趨勢將推動該地區對睡茄萃取物產品的需求。
由於人們對阿育吠陀草藥(包括睡茄萃取物)的使用的廣泛認知以及該地區大量人口的接受,預計北美在預測期內將表現出最高的複合年成長率。人們開始認知到阿育吠陀是瑜伽的姐妹科學。該地區消費者意識的提高和對阿育吠陀藥品的需求不斷成長預計將在市場上獲得巨大的吸引力。此外,美國食品運動營養和營養補充的需求不斷成長可能會在預測期內推動北美睡茄萃取物市場的成長。
According to Stratistics MRC, the Global Ashwagandha Extract Market is accounted for $1.1 billion in 2023 and is expected to reach $2.6 billion by 2030 growing at a CAGR of 13.4% during the forecast period. Ashwagandha extract, derived from the roots of the Withania somnifera plant, is an ancient herb used in Ayurvedic medicine. Renowned for its adaptogenic properties, it helps the body manage stress by regulating cortisol levels. It also supports immune function and enhances overall well-being. Rich in antioxidants, it combats inflammation and may improve brain function, memory, and mood. Moreover, Ashwagandha extract may lower blood sugar levels and reduce symptoms of anxiety and depression.
According to the studies, large doses of ashwagandha could cause upset stomach, diarrhoea, and vomiting, liver problems. It may also irritate the intestinal mucosa, leading to other digestive problems.
Rising awareness of the health benefits of ashwagandha
As more people become aware of the potential health benefits of ashwagandha, there is a corresponding increase in demand for ashwagandha extract products. Consumers are seeking natural remedies for various health concerns, including stress, anxiety, insomnia, and immune support, among others. Further manufacturers are developing new formulations and delivery methods to make ashwagandha extract more accessible and appealing to consumers. This heightened demand is driving growth in the ashwagandha extract market.
Limited clinical research
Without robust clinical research backing its health claims, ashwagandha extract may struggle to gain credibility among healthcare professionals and consumers. Concerns about product quality, purity, and potential side effects may deter some consumers from purchasing ashwagandha extract supplements. Thus the absence of scientific validation can create skepticism and uncertainty about its effectiveness and safety, hindering widespread adoption and market growth.
Growing demand for natural and herbal remedies
As consumers increasingly seek natural alternatives to conventional medicines, the demand for herbal supplements like ashwagandha extract has surged. It attracts not only health-conscious individuals but also those seeking relief from specific health concerns, such as stress, anxiety, fatigue, and sleep disturbances. Ashwagandha's reputation as an adaptogenic herb with potential health benefits for stress relief, immune support, and overall well-being aligns well with the preferences of individuals looking for holistic solutions encourage the growth of the market.
Potential side effects
The presence of potential side effects may attract regulatory scrutiny from health authorities and regulatory agencies. Concerns about consumer safety may prompt regulatory bodies to impose stricter regulations on ashwagandha extract products, including labeling requirements, dosage restrictions, or even potential bans in certain regions. This can hinder market access and growth for manufacturers and distributors.
Covid-19 Impact
Increased awareness of ashwagandha's adaptogenic properties and its traditional use in Ayurvedic medicine have fueled demand for supplements and extracts. Lockdowns and health concerns have accelerated the shift towards online purchasing channels, driving further market growth. Additionally, research suggesting potential antiviral and immune-modulatory effects of ashwagandha has sparked interest among consumers and researchers alike, contributing to the resilience of the market amidst the pandemic's challenges.
The hydro-alcoholic ashwagandha segment is expected to be the largest during the forecast period
The hydro-alcoholic ashwagandha segment is estimated to have a lucrative growth, as it represents a specific formulation of this herbal extract that may appeal to certain consumers or industries. Hydro-alcoholic extraction is known to yield a concentrated extract with higher potency compared to other extraction methods. This increased potency may appeal to consumers seeking more potent supplements for health benefits which further drives the growth of the market.
The reduced anxiety and stress segment is expected to have the highest CAGR during the forecast period
The reduced anxiety and stress segment is anticipated to witness the highest CAGR growth during the forecast period, as awareness about the link between stress and various health issues grows, more consumers are seeking natural remedies to manage stress and anxiety. Ashwagandha, with its reputation as an adaptogen, becomes an attractive option for individuals looking for natural stress-relief solutions. This expansion of the consumer base can lead to increased sales and market growth.
Asia Pacific is projected to hold the largest market share during the forecast period. Ashwagandha is a traditional Ayurvedic herb that has been used for centuries to treat a variety of health conditions. With the growing popularity of natural and organic products, consumers in the Asia Pacific region are becoming increasingly aware of the potential health benefits of ashwagandha. These benefits include reducing stress and anxiety, improving sleep quality, boosting immunity, and increasing energy levels. This trend is expected to drive the demand for ashwagandha extract products in the region.
North America is projected to have the highest CAGR over the forecast period, due to extensive awareness about using ayurvedic herbs medicines including ashwagandha extract and acceptance by the large population in the region. People are beginning to discover ayurveda as a sister science of yoga. Increasing consumer awareness and growing demand for ayurvedic medicines products in the region is expected to gain a major traction in the market. Furthermore, growing demand for sports nutrition and dietary supplement in the U.S. is likely to boost the growth of the North America ashwagandha extract market during the forecast period.
Key players in the market
Some of the key players in the Ashwagandha Extract Market include Apex International, Banyan Botanicals Corporation, Dabur India Limited, Himalaya Herbal Healthcare, Kerry Group plc, KSM66 Ashwagandha, Medikonda Nutrients, Natreon Inc, Nature's Answer Inc., NOW Foods Co., Organic India PVT Ltd., Paradise Herbs & Essentials Inc., Patanjali AyurvedIndia, Planetary Herbals Co., Sami-Sabinsa Group, Solaray Inc., Solgar Inc., Swanson Health Products Inc. and Zoic Pharmaceuticals
In March 2024, Banyan Botanicals and other companies in the natural products sector will collaborate to establish data on the greenhouse gas emissions associated with the agricultural production of herbs.
In January 2024, Kerry completes acquisition of science-backed branded botanical extract company Natreon. The branded ingredients in Natreon's portfolio are protected by a wide range of U.S. and foreign patents and supported by a total of 52 clinical studies which support the efficacy of their health benefits.
In January 2024, Tata Consumer Products Ltd (TCPL) announced that it would acquire 100% of Organic India's equity shares. The acquisition will include TCPL's purchase of Capital Foods, the owner of Organic India and Ching's Secret, and Smith & Jones.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.